Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02525718 · ClinicalTrials.gov registry record · Phase 2
Selective Intraoperative Administration of Local Anesthesia in Breast Reconstruction
A Phase 2 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 2
- Development phase
- 47
- Enrollment target
NCT02525718 is a Phase 2 study that has completed, run by Northwestern University. The registered enrollment target is 47 participants.
The verdict
NCT02525718, a Phase 2 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 47 participants
- Enrollment target
Study Summary
Subjects are being asked to participate in this study because they will be undergoing unilateral (one) or bilateral (two) mastectomy surgery with immediate reconstruction involving insertion of a tissue expander.
Interventions
- DRUG Saline
- DRUG 0.25 % bupivacaine (2.5 mg/ml) w/ 1:100,000 epinephrine & 4 mg dexamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2015-08 |
| Est. Completion | 2017-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02525718
The ClinicalTrials.gov registry entry for NCT02525718 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT02525718 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02525718 about?
NCT02525718 is a clinical study titled "Selective Intraoperative Administration of Local Anesthesia in Breast Reconstruction". Subjects are being asked to participate in this study because they will be undergoing unilateral (one) or bilateral (two) mastectomy surgery with immediate reconstruction involving insertion of a tissue expander.
What is the current status of trial NCT02525718?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 47 participants. The study started on 2015-08. Estimated completion is 2017-03.
What interventions are being tested in trial NCT02525718?
The interventions under investigation include: Saline (DRUG), 0.25 % bupivacaine (2.5 mg/ml) w/ 1:100,000 epinephrine & 4 mg dexamethasone (DRUG).
Who is sponsoring clinical trial NCT02525718?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.